切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2022, Vol. 12 ›› Issue (01) : 46 -51. doi: 10.3877/cma.j.issn.2095-2015.2022.01.011

综述

非酒精性脂肪性胰腺疾病的研究进展
许莹1, 马霄虹1, 赵心明1,()   
  1. 1. 100021 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院影像诊断科
  • 收稿日期:2021-03-25 出版日期:2022-02-01
  • 通信作者: 赵心明

Research progress of nonalcoholic fatty pancreas disease

Ying Xu1, Xiaohong Ma1, Xinming Zhao1,()   

  1. 1. Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2021-03-25 Published:2022-02-01
  • Corresponding author: Xinming Zhao
引用本文:

许莹, 马霄虹, 赵心明. 非酒精性脂肪性胰腺疾病的研究进展[J]. 中华消化病与影像杂志(电子版), 2022, 12(01): 46-51.

Ying Xu, Xiaohong Ma, Xinming Zhao. Research progress of nonalcoholic fatty pancreas disease[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2022, 12(01): 46-51.

非酒精性脂肪性胰腺疾病(NAFPD)是指与肥胖症或代谢综合征相关的胰腺脂肪堆积。近年来随着人们生活水平的提高,NAFPD发病率也在不断增加,与其相关的研究也随之增加。目前其发病机制尚不明确,定量评估方法主要包括组织学检查、超声、CT、MRI等,近年来文献报道NAFPD与疾病的相关性主要集中于2型糖尿病、动脉粥样硬化、代谢综合征、胰腺癌、胰腺内分泌与外分泌功能、非酒精性脂肪肝、急慢性胰腺炎、胰瘘等。与肝脏脂肪变性相比,NAFPD相关研究数量依然较少。

Nonalcoholic fatty pancreas disease(NAFPD)refers to the accumulation of pancreatic fat related to obesity or metabolic syndrome.In recent years, with the improvement of people′s living standards, its incidence is also increasing, and the related research is also increasing.At present, its pathogenesis is unclear, and the quantitative evaluation methods mainly include histological examination, ultrasound, CT, MRI, etc.According to studies in recent years, its correlation with diseases mainly focuses on type 2 diabetes, atherosclerosis, metabolic syndrome, pancreatic cancer, pancreatic endocrine and exocrine function, nonalcoholic fatty liver, acute and chronic pancreatitis, pancreatic fistula and so on.Compared with hepatic steatosis, the number of studies related to NAFPD is still small.

表1 胰腺中脂肪的命名汇总[4,5]
1
Ogilvie RF.The islands of langerhans in 19 cases of obesity [J].J Pathol Bacteriol193337(3):473-481.
2
Wang CY,,Ou HY,,CHEN MF,et al.Enigmatic ectopic fat:prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population [J].J Am Heart Assoc20143(1):e000297.
3
Zhou J,,Li ML,,Zang DD,et al.The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population [J].Pancreatology201616(4):578-583.
4
Dite P,,Blaho M,,Bojkova M,et al.Nonalcoholic Fatty Pancreas Disease:Clinical Consequences [J].Dig Dis202038(2):143-149.
5
Smits MM,,Van Geenen EJ.The clinical significance of pancreatic steatosis [J].Nat Rev Gastroenterol Hepatol20118(3):169-177.
6
Catanzaro R,,Cuffari B,,Italia A,et al.Exploring the metabolic syndrome:Nonalcoholic fatty pancreas disease [J].World J Gastroenterol201622(34):7660-7675.
7
Bobulescu IA,,Lotan Y,,Zhang J,et al.Triglycerides in the human kidney cortex:relationship with body size [J].PLoS One20149(8):e101285.
8
Van GEENEN EJ,,Smits MM,,Schreuder TC,et al.Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease [J].Pancreas201039(8):1185-1190.
9
Carter R,,Mouralidarane A,,Soeda J,et al.Non-alcoholic fatty pancreas disease pathogenesis:a role for developmental programming and altered circadian rhythms [J].PLoS One20149(3):e89505.
10
Lingvay I,,Esser V,,Legendre JL,et al.Noninvasive quantification of pancreatic fat in humans [J].J Clin Endocrinol Metab200994(10):4070-4076.
11
Olsen TS.Lipomatosis of the pancreas in autopsy material and its relation to age and overweight [J].Acta Pathol Microbiol Scand A197886A(5):367-373.
12
Stamm BH.Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy:a systematic study of 112 autopsies in patients without known pancreatic disease [J].Hum Pathol198415(7):677-683.
13
Saisho Y,,Butler AE,,Meier JJ,et al.Pancreas volumes in humans from birth to age one hundred taking into account sex,obesity,and presence of type-2 diabetes [J].Clin Anat200720(8):933-942.
14
Midiri M,,Lo Casto A,,Sparacia G,et al.MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major [J].AJR Am J Roentgenol1999173(1):187-192.
15
Robertson MB,,Choe KA,,Joseph PM.Review of the abdominal manifestations of cystic fibrosis in the adult patient [J].Radiographics200626(3):679-690.
16
Raeder H,,Haldorsen IS,,Ersland L,et al.Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase [J].Diabetes200756(2):444-449.
17
Daentl DL,,Frias JL,,Gilbert EF,et al.The Johanson-Blizzard syndrome:case report and autopsy findings [J].Am J Med Genet19793(2):129-135.
18
Walters MN.Adipose atrophy of the exocrine pancreas [J].J Pathol Bacteriol196692(2):547-557.
19
Fullenkamp AM,,Bell LN,,Robbing RD,et al.Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine [J].Pancreas201140(3):438-443.
20
Grippo PJ,,Fitchev PS,,Bentrem DJ,et al.Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice [J].Gut201261(10):1454-1464.
21
Lee Y,,Lingvay I,,Szczepaniak LS,et al.Pancreatic steatosis:harbinger of type 2 diabetes in obese rodents [J].Int J Obes(Lond)201034(2):396-400.
22
Oben J A,,Patel T,,Mouralidarane A,et al.Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease [J].Biochem Biophys Res Commun2010394(1):24-28.
23
Belyaev O,,Munding J,,Herzog T,et al.Histomorphological features of the pancreatic remnant as independent risk factors for postoperative pancreatic fistula:a matched-pairs analysis [J].Pancreatology201111(5):516-524.
24
Gaujoux S,,Cortes A,,Couvelard A,et al.Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy [J].Surgery2010148(1):15-23.
25
Hori M,,Takahashi M,,Hiraoka N,et al.Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma [J].Clin Transl Gastroenterol20145:e53.
26
Kim SY,,Kim H,,Cho JY,et al.Quantitative assessment of pancreatic fat by using unenhanced CT:pathologic correlation and clinical implications [J].Radiology2014271(1):104-112.
27
Rebours V,,Gaujoux S,,D′Assignies G,et al.Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions(PanIN)[J].Clin Cancer Res201521(15):3522-3528.
28
Van Geenen EJ,,Smits MM,,Schreuder TC,et al.Smoking is related to pancreatic fibrosis in humans [J].Am J Gastroenterol2011106(6):1161-1166.
29
Matsumoto S,,Mori H,,Miyake H,et al.Uneven fatty replacement of the pancreas:evaluation with CT [J].Radiology1995194(2):453-458.
30
Jeong HT,,Lee MS,,Kim MJ.Quantitative analysis of pancreatic echogenicity on transabdominal sonography:correlations with metabolic syndrome [J].J Clin Ultrasound201543(2):98-108.
31
Lee JS,,Kim SH,,Jun DW,et al.Clinical implications of fatty pancreas:correlations between fatty pancreas and metabolic syndrome [J].World J Gastroenterol200915(15):1869-1875.
32
Ustundag Y,,Ceylan G,,Hekimoglu K.Pancreatic hyperechogenicity on endoscopic ultrasound examination [J].World J Gastroenterol201117(15):2061-2062.
33
Navina S,,Acharya C,,Delany JP,et al.Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity [J].Sci Transl Med20113(107):107ra10.
34
Mathur A,,Hernandez J,,Shaheen F,et al.Preoperative computed tomography measurements of pancreatic steatosis and visceral fat:prognostic markers for dissemination and lethality of pancreatic adenocarcinoma [J].HPB(Oxford)201113(6):404-410.
35
Roberts K J,,Storey R,,Hodson J,et al.Pre-operative prediction of pancreatic fistula:is it possible? [J].Pancreatology201313(4):423-428.
36
Ly JN,,Miller FH.MR imaging of the pancreas:a practical approach [J].Radiol Clin North Am200240(6):1289-1306.
37
Gaborit B,,Abdesselam I,,Kober F,et al.Ectopic fat storage in the pancreas using 1H-MRS:importance of diabetic status and modulation with bariatric surgery-induced weight loss [J].Int J Obes(Lond)201539(3):480-487.
38
Hannukainen JC,,Borra R,,Linderborg K,et al.Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity [J].J Hepatol201154(3):545-552.
39
Hu HH,,Kim H W,,Nayak KS,et al.Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans [J].Obesity(Silver Spring)201018(4):841-847.
40
Begovatz P,,Koliaki C,,Weber K,et al.Pancreatic adipose tissue infiltration,parenchymal steatosis and beta cell function in humans [J].Diabetologia201558(7):1646-1655.
41
Ma J,,Song Z,,Yan F.Detection of hepatic and pancreatic fat infiltration in type II diabetes mellitus patients with IDEAL-Quant using 3.0T MR:comparison with single-voxel proton spectroscopy [J].Chin Med J(Engl)2014127(20):3548-3552.
42
Schwenzer NF,,Machann J,,Martirosian P,et al.Quantification of pancreatic lipomatosis and liver steatosis by MRI:comparison of in/opposed-phase and spectral-spatial excitation techniques [J].Invest Radiol200843(5):330-337.
43
Yu H,,Shimakawa A,,Mckenzie CA,et al.Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling [J].Magn Reson Med200860(5):1122-1134.
44
Ou HY,,Wang CY,,Yang YC,et al.The association between nonalcoholic fatty pancreas disease and diabetes [J].PLoS One20138(5):e62561.
45
Tushuizen ME,,Bunck MC,,Pouwels PJ,et al.Pancreatic fat content and beta-cell function in men with and without type 2 diabetes [J].Diabetes Care200730(11):2916-2921.
46
Heni M,,Machann J,,Staiger H,et al.Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance:a nuclear magnetic resonance study [J].Diabetes Metab Res Rev201026(3):200-205.
47
Van Raalte DH,,Van DER ZIJL NJ,,Diamant M.Pancreatic steatosis in humans:cause or marker of lipotoxicity? [J].Curr Opin Clin Nutr Metab Care201013(4):478-485.
48
Szendroedi J,,Roden M.Ectopic lipids and organ function [J].Curr Opin Lipidol200920(1):50-56.
49
Kul S,,Karadeniz A,,Dursun I,et al.Non-Alcoholic Fatty Pancreas Disease is Associated with Increased Epicardial Adipose Tissue and Aortic Intima-Media Thickness [J].Acta Cardiol Sin201935(2):118-125.
50
Alberti KG,,Eckel RH,,Grundy SM,et al.Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;National Heart,Lung,and Blood Institute;American Heart Association;World Heart Federation;International Atherosclerosis Society;and International Association for the Study of Obesity [J].Circulation2009120(16):1640-1645.
51
Bi Y,,Wang JL,,Li M L,et al.The association between pancreas steatosis and metabolic syndrome:A systematic review and meta-analysis [J].Diabetes Metab Res Rev201935(5):e3142.
52
Tomita Y,,Azuma K,,Nonaka Y,et al.Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma [J].Pancreas201443(7):1032-1041.
53
Zyromski NJ,,Mathur A,,Pitt HA,et al.Obesity potentiates the growth and dissemination of pancreatic cancer [J].Surgery2009146(2):258-263.
54
Lesmana CRA,,Gani RA,,Lesmana LA.Non-alcoholic fatty pancreas disease as a risk factor for pancreatic cancer based on endoscopic ultrasound examination among pancreatic cancer patients:A single-center experience [J].JGH Open20182(1):4-7.
55
Wu Q,,Chen G,,Wu WM,et al.Metabolic syndrome components and risk factors for pancreatic adenocarcinoma:a case-control study in China [J].Digestion201286(4):294-301.
56
Abbruzzese JL,,Andersen DK,,Borrebaeck CAK,et al.The Interface of Pancreatic Cancer With Diabetes,Obesity,and Inflammation:Research Gaps and Opportunities:Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop [J].Pancreas201847(5):516-525.
57
Philip B,,Roland CL,,Daniluk J,et al.A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice [J].Gastroenterology2013145(6):1449-1458.
58
Desai V,,Patel K,,Sheth R,et al.Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma [J].Visc Med202036(3):220-226.
59
Mathur A,,Zyromski N J,,Pitt H A,et al.Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer [J].J Am Coll Surg2009208(5):989-994.
60
Savvina T V.[A histotopographic study of the pancreas in lipomatosis][J].Arkh Patol197638(1):68-73.
61
Miyake H,,Sakagami J,,Yasuda H,et al.Association of fatty pancreas with pancreatic endocrine and exocrine function [J].PLoS One201813(12):e0209448.
62
Pezzilli R,,Andriulli A,,Bassi C,et al.Exocrine pancreatic insufficiency in adults:a shared position statement of the Italian Association for the Study of the Pancreas [J].World J Gastroenterol201319(44):7930-7946.
63
Tahtaci M,,Algin O,,Karakan T,et al.Can pancreatic steatosis affect exocrine functions of pancreas? [J].Turk J Gastroenterol201829(5):588-594.
64
Acharya C,,Cline RA,,Jaligama D,et al.Fibrosis reduces severity of acute-on-chronic pancreatitis in humans [J].Gastroenterology2013145(2):466-475.
65
Ronti T,,Lupattelli G,,Mannarino E.The endocrine function of adipose tissue:an update [J].Clin Endocrinol(Oxf)200664(4):355-365.
66
Zyromski NJ,,Mathur A,,Pitt HA,et al.A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis [J].Am J Physiol Gastrointest Liver Physiol2008295(3):G552-558.
67
Honka H,,Koffert J,,Hannukainen JC,et al.The effects of bariatric surgery on pancreatic lipid metabolism and blood flow [J].J Clin Endocrinol Metab2015100(5):2015-2023.
[1] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[2] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[3] 郑希彦, 周正, 何方平, 林志群, 杜飞, 谢琴, 王少平, 史宪杰. 代谢综合征与乙型肝炎病毒相关性肝细胞癌预后的危险因素分析[J]. 中华普通外科学文献(电子版), 2023, 17(02): 104-109.
[4] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[5] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[6] 谯钰琪, 惠盼, 南岩东. DGKζ的结构功能及研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 117-120.
[7] 李青原, 冯同, 邱雪琴, 李万成. 迷迭香提取物防治肺纤维化研究进展[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 908-911.
[8] 王冠, 徐兴祥. 吸入药物在慢性阻塞性肺疾病和肺癌中的应用及进展[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 904-907.
[9] 秦富豪, 郑正, 江滨. 间充质干细胞在克罗恩病肛瘘治疗中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 172-177.
[10] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[11] 栾恒钰, 赛晓勇. 创伤后应激障碍的治疗现状及研究进展[J]. 中华神经创伤外科电子杂志, 2023, 09(02): 112-118.
[12] 黄文鹏, 邱永康, 杨琦, 宋乐乐, 陈钊, 范岩, 康磊. PET相关影像组学在肿瘤预后中的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 104-110.
[13] 吴一菡, 雷章, 卢宏达. MUC16/CA125在良恶性肿瘤诊治中的作用及其研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 591-595.
[14] 肖国中, 林宏城. 大便失禁治疗技术的研究进展[J]. 中华临床医师杂志(电子版), 2022, 16(07): 696-700.
[15] 晋连超, 杨冰, 周哲, 潘东亮, 谢遵珂. 代谢综合征与女性压力性尿失禁相关性研究[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 109-113.
阅读次数
全文


摘要